Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz
Media Pack
News

Current Edition

Volume 18, Issue 1
Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026
Volume 16 Issue 1

Advancing Therapeutic Solutions with Antibody-drug Conjugates (ADCs)

As promising therapeutic agents for treating oncology indications, antibody-drug conjugates (ADCs) have become prominent in the biopharmaceutical market in recent ye...
15 April 2024 Volume 16 Issue 1 | Editorial Archive ADCs | Advancing
Continue Reading →
Volume 15 Issue 3

Antibody Drug Conjugates and the Link to Fighting Cancer

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...
29 September 2023 Volume 15 Issue 3 ADCs | antibody
Continue Reading →
News

FDA approves single-vial version of GSK’s Menveo vaccine, ending need for reconstitution

GSK has won FDA approval for a single-vial formulation of its meningococcal disease vaccine Menveo, thereby ending the need for reconstitution that has existed since...
19 October 2022 News antibody | FDA approval
Continue Reading →
News

AstraZeneca’s long-acting antibody combination treats and prevents COVID-19

Positive high-level results from the TACKLE Phase III COVID-19 treatment trial have shown that AstraZeneca’s AZD7442, a long-acting antibody (LAAB) combination, achi...
13 October 2021 News antibody | AstraZeneca
Continue Reading →
News

Roche withdraws US approval for Tecentriq in mTNBC

Roche has voluntarily withdrawn its US accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for the treatment of adults with unresectab...
1 September 2021 News antibody | atezolizumab
Continue Reading →
News

HK researchers invent universal antibody drug against HIV/AIDS

A team led by Professor Chen Zhiwei at Hong Kong University’s AIDS Institute says its discovery, tested on mice, shows the new antibody can help control the vir...
19 June 2018 News antibody | drug
Continue Reading →
News

Univercells granted €2.4M ($2.9M) to develop antibody production platform

Univercells SA, a technology company dedicated to delivering innovative and cost-effective biomanufacturing solutions, today announces that it has received a grant&...
25 January 2018 News antibody | auto-immune
Continue Reading →
News

Avacta Group plc announces positive outcome of proof-of-concept study with Glythera and follow-on drug development partnership

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that its initial study with Glythera Limited, the develo...
16 January 2018 News antibody | biotherapeutics
Continue Reading →
News

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today...
16 January 2018 News antibody | drug discovery
Continue Reading →
News

SYGNIS AG signs supply agreement with US Biological for the Lightning-Link antibody labelling technology

SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with ...
28 November 2017 News antibody | biological
Continue Reading →
SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2026, All Rights Reserved – Powered by Teksyte